14246-77-6

Upstream product

• 42754-56-3 2-(methoxyphenylmethylene)malononitrile 
• 698-16-8 benzohydroximoyl chloride 
• 109-77-3 malononitrile 
• 932-90-1 Benzaldoxime 
• 100-52-7 benzaldehyde 
• 60776-91-2 2-(ethoxy(phenyl)methylene)malononitrile 

Downstream Products

• 14259-10-0 5-benzoylamino-3-phenyl-isoxazole-4-carbonitrile 
• 14259-13-3 N-(4-cyano-3-phenyl-isoxazol-5-yl)-4-methyl-benzamide 
• 14258-81-2 5-(4-chloro-benzoylamino)-3-phenyl-isoxazole-4-carbonitrile 
• 95914-06-0 N-(4-cyano-3-phenyl-isoxazol-5-yl)-formimidic acid ethyl ester 
• 15783-70-7 5-amino-3-phenylisoxazole-4-carboxamide 
• 935-02-4 3-Phenyl-2-propynonitrile 
• 96129-49-6 5-(2-Methoxy-5-methyl-phenyl)-3-phenyl-isoxazole-4-carbonitrile 
• 96129-50-9 5-(5-Methoxy-2-methyl-phenyl)-3-phenyl-isoxazole-4-carbonitrile 

Relevant academic research and scientific papers

Design, synthesis, and biological evaluation of N-(4-substituted)-3-phenylisoxazolo[5,4–d]pyrimidin-4-amine derivatives as apoptosis-inducing cytotoxic agents

A library of new 3-phenylisoxazolo[5,4–d]pyrimidines (8–10) was designed based on a scaffold hybridization technique incorporating the important pharmacophoric features of 4-aminopyrimidine and phenyl isoxazole scaffold which is renowned for its BET inhib

HCV INHIBITING BI-CYCLIC PYRIMIDINES

The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for pre

Alkynes from 5-Aminoisoxazoles

Diazotization of 5-aminoisoxazoles that bear at least one electron-withdrawing group by reaction with sodium nitrite in AcOH-H2O affords substituted acetylenes.A reaction path is proposed.